Table 1.
Demographic characteristics and clinical properties of patients with chronic rhinitis
Control | ECRS | NECRS | p‐value | |
---|---|---|---|---|
No. of subjects | 12 | 26 | 22 | / |
Age (y) | 40.00 ± 8.29 | 45.00 ± 13.00 | 46.51 ± 10.64 | 0.64 |
Sex (M/F) | 6/6 | 12/14 | 10/12 | / |
Nasal polyps | 0 | 8 | 12 | / |
nNO (ppb) | 394.00 ± 70.40 | 526.62 ± 84.00 | 180.27 ± 49.97 | <0. 01 |
PBECs (1 × 109) | 0.25 ± 0.16 | 0.66 ± 0.11 | 0.55 ± 0.15 | <0. 01 |
Serum total IgE (IU) | 135.00 ± 50.18 | 413.00 ± 46.00 | 112.26 ± 58.28 | <0. 01 |
Local infiltrating eosinophilia (%) | 1.00 ± 0.74 | 32.05 ± 3.00 | 7.12 ± 3.30 | <0. 01 |
CRS, chronic rhinosinusitis; ECRS, eosinophilic CRS; IgE, immunoglobulin E; F, female; FeNO, fractional exhaled nitric oxide; Local infiltrating eosinophilia (%), eosinophils/total inflammatory cells; M, male; NECRS, non‐ECRS; PBEC, peripheral blood eosinophil cell. Data are presented as mean ± SD. Statistical significance was evaluated by one‐way ANOVA, chi‐squared test, and Tukey's test.